MX2007002875A - Hexadecasacaridos biotinilados, su preparacion y su utilizacion. - Google Patents

Hexadecasacaridos biotinilados, su preparacion y su utilizacion.

Info

Publication number
MX2007002875A
MX2007002875A MX2007002875A MX2007002875A MX2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A MX 2007002875 A MX2007002875 A MX 2007002875A
Authority
MX
Mexico
Prior art keywords
preparation
oso3
c6alkoxy
biotinylated hexadecasaccharides
hexadecasaccharides
Prior art date
Application number
MX2007002875A
Other languages
English (en)
Inventor
Maurice Petitou
Philippe Duchaussoy
Jean-Pascal Herault
Jean Marc Herbert
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007002875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2007002875A publication Critical patent/MX2007002875A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invencion se refiere a nuevos hexadecasaridos biotinilados de al formula general (l) en la cual: - Biot es un derivado de biotina; R, R1 y R2 representan independientemente un alcoxi (C1-C6) o un -OSO3, - R3 representa un alcoxi(C1-C6) o un -OSO3, o bien R3 constituye un puente -O-CH2-; - Pe representa un encadenamiento sacaridico; asi como sus sales farmaceuticamente aceptables, y su uso como medicamentos.
MX2007002875A 2004-09-09 2005-09-07 Hexadecasacaridos biotinilados, su preparacion y su utilizacion. MX2007002875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
MX2007002875A true MX2007002875A (es) 2007-05-16

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002875A MX2007002875A (es) 2004-09-09 2005-09-07 Hexadecasacaridos biotinilados, su preparacion y su utilizacion.

Country Status (39)

Country Link
US (3) US20070270342A1 (es)
EP (1) EP1791872B1 (es)
JP (1) JP5108519B2 (es)
KR (1) KR101223364B1 (es)
CN (1) CN101039963B (es)
AR (1) AR051286A1 (es)
AT (1) ATE420118T1 (es)
AU (1) AU2005284080B2 (es)
BR (1) BRPI0515078A (es)
CA (1) CA2577258C (es)
CY (1) CY1109126T1 (es)
DE (1) DE602005012287D1 (es)
DK (1) DK1791872T3 (es)
EA (1) EA012587B1 (es)
EC (1) ECSP077272A (es)
ES (1) ES2320576T3 (es)
FR (1) FR2874924B1 (es)
GT (1) GT200500250A (es)
HK (1) HK1113686A1 (es)
HN (1) HN2005000518A (es)
HR (1) HRP20090180T1 (es)
IL (1) IL181569A (es)
MA (1) MA28859B1 (es)
MX (1) MX2007002875A (es)
MY (1) MY140666A (es)
NI (1) NI200700063A (es)
NO (1) NO20071754L (es)
PA (1) PA8644201A1 (es)
PE (1) PE20060663A1 (es)
PL (1) PL1791872T3 (es)
PT (1) PT1791872E (es)
RS (1) RS50762B (es)
SI (1) SI1791872T1 (es)
SV (1) SV2006002221A (es)
TN (1) TNSN07053A1 (es)
TW (1) TW200612970A (es)
UY (1) UY29102A1 (es)
WO (1) WO2006030104A1 (es)
ZA (1) ZA200702255B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
EP0649854B1 (en) 1993-09-01 2000-03-15 Akzo Nobel N.V. Bisconjugates comprising two saccharides and a spacer
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
NO20071754L (no) 2007-04-02
CN101039963B (zh) 2011-07-27
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
TNSN07053A1 (fr) 2008-06-02
FR2874924A1 (fr) 2006-03-10
KR20070051887A (ko) 2007-05-18
PL1791872T3 (pl) 2009-06-30
PE20060663A1 (es) 2006-08-21
MY140666A (en) 2010-01-15
AU2005284080B2 (en) 2011-10-13
NI200700063A (es) 2008-03-07
EA012587B1 (ru) 2009-10-30
US8703738B2 (en) 2014-04-22
GT200500250A (es) 2006-04-10
KR101223364B1 (ko) 2013-01-16
HRP20090180T1 (en) 2009-05-31
IL181569A0 (en) 2007-07-04
JP5108519B2 (ja) 2012-12-26
UY29102A1 (es) 2006-04-28
MA28859B1 (fr) 2007-09-03
DE602005012287D1 (de) 2009-02-26
ECSP077272A (es) 2007-03-29
PA8644201A1 (es) 2006-05-16
AU2005284080A1 (en) 2006-03-23
BRPI0515078A (pt) 2008-07-01
HK1113686A1 (en) 2008-10-10
SV2006002221A (es) 2006-01-13
ES2320576T3 (es) 2009-05-25
SI1791872T1 (sl) 2009-06-30
CA2577258A1 (fr) 2006-03-23
HN2005000518A (es) 2009-06-01
EP1791872B1 (fr) 2009-01-07
US20100279960A1 (en) 2010-11-04
AR051286A1 (es) 2007-01-03
IL181569A (en) 2011-08-31
US20070270342A1 (en) 2007-11-22
FR2874924B1 (fr) 2006-12-01
DK1791872T3 (da) 2009-05-04
WO2006030104A1 (fr) 2006-03-23
ATE420118T1 (de) 2009-01-15
TW200612970A (en) 2006-05-01
CA2577258C (fr) 2013-05-21
CY1109126T1 (el) 2014-07-02
JP2008512538A (ja) 2008-04-24
CN101039963A (zh) 2007-09-19
PT1791872E (pt) 2009-03-27
US20130004551A1 (en) 2013-01-03
EP1791872A1 (fr) 2007-06-06
EA200700594A1 (ru) 2007-08-31
US8557968B2 (en) 2013-10-15

Similar Documents

Publication Publication Date Title
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
ZA200604719B (en) DPP-IV inhibitors
MX2007002875A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion.
NO20070089L (no) DPP-IV inhibitorer
MY147211A (en) Novel dihydropseudoerythromycin derivatives
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
WO2006048330A8 (en) 11βετα-hsd1 inhibitors
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
WO2009057079A3 (en) Novel pyrimidine derivatives
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2006072458A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
TNSN08191A1 (en) Kinase inhibitors
DE602004024213D1 (en) Aminopropanolderivate
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition

Legal Events

Date Code Title Description
FG Grant or registration